Becton Dickinson and Company (BDX)

Name: Becton Dickinson and Company (BDX) — تاریخچه صورتهای مالی
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

تاریخچه درآمد، سود و جریان نقد از صورت‌های مالی رسمی.

Health Care · وال‌استریت (آمریکا) · آخرین به‌روزرسانی: 2026-08-16

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments.

شاخص‌های کلیدی

ارزش بازار: $50 billion
درآمد (سال مالی منتهی به 2025-09-30): $21.8B
سود خالص: $1.7B
حاشیه سود ناخالص: 45.4%
حاشیه سود خالص: 7.7%

نمودارهای تعاملی و صورت‌های مالی کامل ← مدل ارزش‌گذاری (DCF) ←

صورت سود و زیان سالانه

صورت سود و زیان	TTM → 2026-03-31	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
مجموع درآمد	$21.4B	$21.8B	$20.2B	$19.4B	$18.9B	$19.1B	$16.1B	$17.3B	$16.0B	$12.1B	$12.5B	$10.3B	$8.4B	$8.1B	$7.7B	$7.6B	$7.1B	$7.0B	$7.1B	$6.4B	$5.7B
سود ناخالص	$9.9B	$9.9B	$9.1B	$8.2B	$8.5B	$8.6B	$6.8B	$8.3B	$7.3B	$6.0B	$6.0B	$4.7B	$4.3B	$4.2B	$4.0B	$4.0B	$3.7B	$3.7B	$3.6B	$3.3B	$2.9B
حاشیه سود ناخالص %	46.5%	45.4%	45.2%	42.2%	44.9%	45.1%	42.3%	47.9%	45.5%	49.3%	48.0%	45.7%	50.9%	51.8%	51.3%	52.2%	51.9%	52.6%	51.3%	51.7%	51.3%
سود عملیاتی (EBIT)	$2.3B	$2.6B	$2.4B	$2.1B	$2.3B	$2.2B	$912M	$1.8B	$1.5B	$1.5B	$1.4B	$1.1B	$1.6B	$1.3B	$1.6B	$1.7B	$1.6B	$1.6B	$1.5B	$1.2B	$1.1B
حاشیه سود عملیاتی %	10.6%	11.8%	11.9%	10.9%	12.1%	11.8%	5.7%	10.2%	9.4%	12.6%	11.5%	10.4%	19.0%	15.6%	20.2%	22.0%	22.2%	22.8%	21.7%	18.9%	19.9%
سود خالص	$1.1B	$1.7B	$1.7B	$1.5B	$1.8B	$2.1B	$874M	$1.2B	$311M	$1.1B	$976M	$695M	$1.2B	$1.3B	$1.2B	$1.3B	$1.3B	$1.2B	$1.1B	$890M	$752M
حاشیه سود خالص %	5.3%	7.7%	8.5%	7.7%	9.4%	10.9%	5.4%	7.1%	1.9%	9.1%	7.8%	6.8%	14.0%	16.1%	15.2%	16.8%	18.5%	17.6%	15.9%	14.0%	13.1%
EBITDA	$4.7B	$5.0B	$4.8B	$4.4B	$4.4B	$4.4B	$3.1B	$4.1B	$3.9B	$2.6B	$2.6B	$2.0B	$2.2B	$1.8B	$2.1B	$2.2B	$2.1B	$2.1B	$2.1B	$1.8B	$1.6B
سود هر سهم (EPS)	$3.94	$5.84	$5.86	$5.15	$6.19	$7.16	$3.09	$4.49	$1.18	$4.92	$4.49	$3.35	$5.99	$6.49	$5.59	$5.62	$5.49	$4.99	$4.46	$3.49	$2.93
سهام منتشرشده (میلیون)	281M	287M	291M	288M	287M	292M	282M	275M	265M	224M	218M	208M	198M	199M	209M	226M	240M	247M	253M	255M	257M

منبع: گزارش‌های عمومی شرکت (SEC). پیش از اتکا به هر رقم، آن را در SEC EDGAR بررسی کنید.

ترازنامه‌ها، جریان‌های نقدی، داده‌های فصلی و نسبت‌های مالی کامل در نمایشگر تعاملی BDX در دسترس است. /companies/us/BDX

شرکت‌های مشابه

اطلاعات این وب‌سایت صرفاً برای اهداف آموزشی و اطلاع‌رسانی است و توصیه سرمایه‌گذاری نیست. هیچ هدف قیمتی یا توصیه‌ای منتشر نمی‌شود.

English version →همه سهام

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.